President The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 3rd quarter of 2019. The MD&A would enable the
2019 stood at THB 119.59 million and THB 97.10 million respectively. This is equivalent to a modest decline of 18.81% compared to the same period last year. This signifies that the Company managed to
comparison during year 2019 which is a guideline that can be done according to the requirements of the said financial reporting standards thus group of company choose to adjust list of cumulative happened from
expect to decline low- single digit from effect of COVID-19 and competition, while CAPEX is approximately Bt35bn. 2 2Q20 MD&A Advanced Info Service Plc. Significant Event in 2Q20 1. In Jun-20, AIS
the same period in 2018. The decrease in revenue resulted mainly from the decline of revenues from the manufacturing and selling of Special Cutting Tools segment, which include sales from the Company
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
the Stock Exchange of Thailand Attachment : The reviewed Q3/2019 Financial Statement Far East Fame Line DDB Public Company Limited would like to submit the reviewed Q3/2019 Financial Statements and the
The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 1st quarter of 2020. The MD&A would enable the
2019 showed a loss of Baht 108.49 million, a decline loss of 25%. The Company would like to clarify significant changes of Group’s operation results were summarized as follows: 1. Revenue from sales of
, followed by legal action filed against the company in the Bangkok South Civil Court, which has been accepted by the court. The company will therefore convene the Bondholders' Meeting No. 1/2024